Literature DB >> 15763326

Should we treat patients with chronic hepatitis C on the waiting list?

Gregory T Everson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15763326     DOI： 10.1016/j.jhep.2005.01.012

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia.

Authors:  Harald Hofer; Calin Gurguta; Ulrike Bergholz; Petra Steindl-Munda; Peter Ferenci
Journal:  Wien Klin Wochenschr       Date:  2006-10       Impact factor: 1.704

2.  Prevention of hepatitis C recurrence after liver transplantation: An update.

Authors:  Marco Carbone; Ilaria Lenci; Leonardo Baiocchi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

3.  Role of living donor liver transplantation in the treatment of hepatitis C virus infection.

Authors:  Georgios Tsoulfas; Polyxeni Agorastou
Journal:  Hepat Mon       Date:  2011-06       Impact factor: 0.660

4.  Liver transplant and hepatitis C in methadone maintenance therapy: a case report.

Authors:  Meredith M Hancock; Colette C Prosser; Kanat Ransibrahmanakul; Laura Lester; Elana Craemer; James A Bourgeois; Lorenzo Rossaro
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.